Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - LIBERATOR MEDICAL HOLDINGS, INC. | v340779_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 5, 2013
LIBERATOR MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
| NEVADA | 000-05663 | 87-0267292 |
| (State or other jurisdiction | (Commission | (IRS Employer |
| Of incorporation) | File Number) | Identification Number) |
| 2979 SE Gran Park Way, Stuart, Florida 34997 |
| (Address of Principal Executive Offices) |
| (772) 287-2414 |
| (Registrant’s telephone number, including area code) |
| (Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
| (d) | Exhibits |
| Exhibit No. | Description |
| 99.1 | Press release issued by Liberator Medical Holdings, Inc., on April 5, 2013. |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
| LIBERATOR MEDICAL HOLDINGS, INC. | ||
| Registrant | ||
| Dated: April 8, 2013 | /s/ Robert J. Davis |
|
Robert J. Davis, Chief Financial Officer |
| 3 |